Mazen Noureddin, MD
Director, Cedars-Sinai Fatty Liver Program
Clinical Office
Liver Disease & Transplant Center
8900 Beverly Blvd - 3rd Floor
Los Angeles, CA
90048
Phone:
310-423-6000
Fax:
310-423-2356
Mazen Noureddin, MD
Director, Cedars-Sinai Fatty Liver Program
Specialty
- IM/Gastroenterology
Subspecialty
- Fatty Liver Disease
- Hepatology
Research Profile
The research of Mazen Noureddin, MD, focuses on the underlying mechanisms of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), new imaging modalities and exploring new treatments. He has conducted several original studies that have been featured in publications such as Gastroenterology, Hepatology and The American Journal of Gastroenterology, among many others. The Fatty Liver Program at Cedars-Sinai has many breakthrough clinical trials targeting new therapies in patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitisn (NASH), including those with advanced fibrosis and cirrhosis.
Education
- Residency: University of Southern California, 2005
- Fellowship: National Institutes of Health, 2008
- Master's: Duke University School of Medicine, 2009
- Fellowship: University of California, San Diego School of Medicine, 2011
Languages Spoken
English / Arabic
Make an Appointment